2. Academic Validation
  3. Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors

Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors

  • Bioorg Med Chem. 2008 Mar 15;16(6):3218-23. doi: 10.1016/j.bmc.2007.12.021.
Zhongze Ma 1,  Wei Xu,  Lee-Yuan Liu-Chen,  David Y W Lee
Affiliations

Affiliation

  • 1 Bio-Organic and Natural Products Laboratory, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA.
PMID: 18166466 DOI: 10.1016/j.bmc.2007.12.021
Abstract

Bioactivity-guided fractionation of Notopterygium forbesii has resulted in the isolation of one new coumarin glycoside and one new phenethyl vanillate, together with seventeen known compounds. The structures of these compounds were characterized by spectroscopic methods. These compounds were evaluated for their binding affinities to the opioid and dopamine receptors, and falcarindiol showed weak binding affinities to opioid receptors and moderate affinity for D1 receptor (K(i)=192+/-6 nM).

Figures
Products